A strong Research and Development capability is the core attribute of any great organisation. It is a key to growth and sustainability. At Supriya Lifescience Ltd., we invest in only the finest infrastructure and people skills in this critical area.
Supriya Lifescience Ltd. has a proven track record of delivering Active Pharmaceutical Ingredients (APIs) and Intermediates to our global clients over 3 decades. Our R&D division partners with innovator and generic companies to develop innovative, cost-effective and safe processes for NCEs, Generic molecules and support life-cycle management of products for global clients.
Our R&D division is approved by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Govt. Of India; and has also partnered with internationally acclaimed educational institutes like – The Institute of Chemical Technology, Mumbai.
At Supriya Lifescience Ltd., many hazardous processes are performed at commercial scale which are developed in R&D and successfully scaled up. The complex chemistries are performed in addition to the following range:
- Friedel Craft’s Acylation
- Claisen Condensation
- Grignard Reaction
- Mannich Reaction
- Ritter Reaction
- Eschweiller Clark Reaction
The current activities include
- Process development of generic APIs and Intermediates
- Route scouting, process research for Custom Synthesis and manufacturing products
- Life-cycle management of existing products
- Development of non-infringing processes
- Trouble-shooting support to plant
- Providing support to QA for Regulatory filing.